Vipin Chandra: India Has the Potential to Build the World’s Most Powerful ART Registry
Vipin Chandra, Director at Matcare Maternity, shared a post on LinkedIn:
“India Has the Potential to Build the World’s Most Powerful ART Registry — But We Must Move Beyond Compliance
As one of the fastest-growing IVF ecosystems globally, India today performs an estimated >250,000 ART cycles annually across nearly 2,000+ clinics. Yet, when we compare ourselves with mature global ART registries like:
- SART (USA)
- HFEA (UK)
- ANZARD (Australia and New Zealand)
- ESHRE/ICMART (Europe)
it becomes clear that India’s ART registry journey is still in its early foundational phase.
The introduction of the National ART and Surrogacy Registry Portal under the ART Act 2021 is undoubtedly a landmark step and has laid the groundwork for a unified reproductive medicine ecosystem in India.
However, globally leading registries have evolved far beyond basic cycle reporting.
Today, mature ART registries track:
- Cumulative live birth rates
- Singleton live birth rates
- Perinatal and neonatal outcomes
- OHSS and adverse events
- Embryology KPIs
- Donor traceability
- Longitudinal patient outcomes
- Real-world national trend data
- Public clinic benchmarking
- AI-driven predictive analytics
- Patient-facing success prediction tools
In comparison, India’s current ART portal still has major gaps in:
- Live birth outcome tracking
- Public transparency dashboards
- Embryology and clinical KPI benchmarking
- Real-time reporting
- Research-grade anonymized datasets
- Independent audit and data validation systems
- Perinatal/neonatal outcome integration
Countries like the UK (HFEA) and USA (SART) have demonstrated how transparent, validated, patient-facing ART registries.
India has one major advantage over most countries:
Scale.
No other country may eventually generate the depth and diversity of ART data India potentially can.
If structured correctly, India could become:
The world’s largest real-world reproductive medicine database.
But to achieve this, the next phase of the Indian ART Registry must focus on:
- ICMART-aligned standardized datasets
- Mandatory live birth and neonatal reporting
- Embryology and laboratory KPI integration
- AI-enabled outcome analytics
- National benchmarking systems
- Public transparency portals
- Research data access
- Integration with maternal and neonatal outcomes
- Quality audits and validation framework
- Patient-centric reporting metrics
Importantly, Indian ART programs should gradually move from measuring:
‘pregnancy per transfer’ toward:
- cumulative live birth
- singleton healthy birth
- maternal safety
- neonatal outcomes
because modern ART success is no longer only about creating pregnancy — it is about creating healthier mothers and healthier babies safely.
The future of reproductive medicine globally will increasingly be driven by:
- Data quality
- Real-world evidence
- AI-integrated analytics
- Transparent clinical benchmarking
India now has the opportunity not just to participate in that future but potentially lead it.”

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 1, 2026, 10:43Gynecologic Conditions in the Context of Incarceration – IJGO
-
Jun 1, 2026, 10:41Asma Khalil: AI in Placenta Accreta Detection With Earlier Diagnosis and the Future of High-Risk Pregnancy Care
-
May 31, 2026, 18:26Christopher Robinson: Obstetric Procedures That May Be Added to Vaginal Clamping to Stop PPH
-
May 31, 2026, 18:08The Fear Around IVF and Cancer Has Never Matched the Data – Fertility Plus
-
May 31, 2026, 17:57Luciana Chamie: My Go-To Tips for High Quality Dedicated Endometriosis Mapping TVUS
-
May 31, 2026, 17:46Sometimes the Signs Are Subtle, and Sometimes the Answers Are Not Immediately Visible on a Scan – The Ectopic Pregnancy Trust
-
May 31, 2026, 17:37Sujoy Dasgupta: How Smoking Increases Pregnancy Complications
-
May 31, 2026, 17:27Demián Glujovsky: Grateful to Participate Once Aagain in Debates in Fertility in Cuernavaca
-
May 31, 2026, 13:26Under 38 and Can’t Get Pregnant? Why IUI is a Game-Changer – Fertility Plus
